[1]
“A STUDY TO ASSESS THE DISTRIBUTION OF SUSPECTED ADVERSE EVENTS FOLLOWING IMMUNISATION REPORTED IN A METROPOLITAN CITY IN INDIA”, Glob. j. public health med., vol. 7, no. 1, pp. 14–25, Jan. 2025, doi: 10.37557/gjphm.v7i1.282.